232 related articles for article (PubMed ID: 18469093)
1. Disruption of the homeostatic balance between autoaggressive (CD4+CD40+) and regulatory (CD4+CD25+FoxP3+) T cells promotes diabetes.
Waid DM; Vaitaitis GM; Pennock ND; Wagner DH
J Leukoc Biol; 2008 Aug; 84(2):431-9. PubMed ID: 18469093
[TBL] [Abstract][Full Text] [Related]
2. An alternative role for Foxp3 as an effector T cell regulator controlled through CD40.
Vaitaitis GM; Carter JR; Waid DM; Olmstead MH; Wagner DH
J Immunol; 2013 Jul; 191(2):717-25. PubMed ID: 23776180
[TBL] [Abstract][Full Text] [Related]
3. High distribution of CD40 and TRAF2 in Th40 T cell rafts leads to preferential survival of this auto-aggressive population in autoimmunity.
Vaitaitis GM; Wagner DH
PLoS One; 2008 Apr; 3(4):e2076. PubMed ID: 18446238
[TBL] [Abstract][Full Text] [Related]
4. Effector and naturally occurring regulatory T cells display no abnormalities in activation induced cell death in NOD mice.
Kaminitz A; Yolcu ES; Askenasy EM; Stein J; Yaniv I; Shirwan H; Askenasy N
PLoS One; 2011; 6(6):e21630. PubMed ID: 21738739
[TBL] [Abstract][Full Text] [Related]
5. Idd9.1 locus controls the suppressive activity of FoxP3+CD4+CD25+ regulatory T-cells.
Yamanouchi J; Puertas MC; Verdaguer J; Lyons PA; Rainbow DB; Chamberlain G; Hunter KM; Peterson LB; Wicker LS; Santamaria P
Diabetes; 2010 Jan; 59(1):272-81. PubMed ID: 19833887
[TBL] [Abstract][Full Text] [Related]
6. Diabetes in non-obese diabetic mice is not associated with quantitative changes in CD4+ CD25+ Foxp3+ regulatory T cells.
Mellanby RJ; Thomas D; Phillips JM; Cooke A
Immunology; 2007 May; 121(1):15-28. PubMed ID: 17428252
[TBL] [Abstract][Full Text] [Related]
7. APC activation restores functional CD4(+)CD25(+) regulatory T cells in NOD mice that can prevent diabetes development.
Manirarora JN; Kosiewicz MM; Parnell SA; Alard P
PLoS One; 2008; 3(11):e3739. PubMed ID: 19011680
[TBL] [Abstract][Full Text] [Related]
8. CD40-mediated signalling influences trafficking, T-cell receptor expression, and T-cell pathogenesis, in the NOD model of type 1 diabetes.
Vaitaitis GM; Waid DM; Yussman MG; Wagner DH
Immunology; 2017 Oct; 152(2):243-254. PubMed ID: 28542921
[TBL] [Abstract][Full Text] [Related]
9. Adaptive TGF-beta-dependent regulatory T cells control autoimmune diabetes and are a privileged target of anti-CD3 antibody treatment.
You S; Leforban B; Garcia C; Bach JF; Bluestone JA; Chatenoud L
Proc Natl Acad Sci U S A; 2007 Apr; 104(15):6335-40. PubMed ID: 17389382
[TBL] [Abstract][Full Text] [Related]
10. Dendritic cells with TGF-beta1 differentiate naive CD4+CD25- T cells into islet-protective Foxp3+ regulatory T cells.
Luo X; Tarbell KV; Yang H; Pothoven K; Bailey SL; Ding R; Steinman RM; Suthanthiran M
Proc Natl Acad Sci U S A; 2007 Feb; 104(8):2821-6. PubMed ID: 17307871
[TBL] [Abstract][Full Text] [Related]
11. Differences in T regulatory cells between mouse strains frequently used in immunological research: Treg cell quantities and subpopulations in NOD, B6 and BALB/c mice.
Godoy GJ; Paira DA; Olivera C; Breser ML; Sanchez LR; Motrich RD; Rivero VE
Immunol Lett; 2020 Jul; 223():17-25. PubMed ID: 32330480
[TBL] [Abstract][Full Text] [Related]
12. Induction of CD4
Khosravi M; Bidmeshkipour A; Cohen JL; Moravej A; Hojjat-Assari S; Naserian S; Karimi MH
Stem Cell Res Ther; 2018 Oct; 9(1):273. PubMed ID: 30359308
[TBL] [Abstract][Full Text] [Related]
13. CD4(+)CD25(+) T-cells control autoimmunity in the absence of B-cells.
Mariño E; Villanueva J; Walters S; Liuwantara D; Mackay F; Grey ST
Diabetes; 2009 Jul; 58(7):1568-77. PubMed ID: 19336675
[TBL] [Abstract][Full Text] [Related]
14. Cyclophosphamide-induced type-1 diabetes in the NOD mouse is associated with a reduction of CD4+CD25+Foxp3+ regulatory T cells.
Brode S; Raine T; Zaccone P; Cooke A
J Immunol; 2006 Nov; 177(10):6603-12. PubMed ID: 17082572
[TBL] [Abstract][Full Text] [Related]
15. Blockade of TGF-β signaling to enhance the antitumor response is accompanied by dysregulation of the functional activity of CD4
Polanczyk MJ; Walker E; Haley D; Guerrouahen BS; Akporiaye ET
J Transl Med; 2019 Jul; 17(1):219. PubMed ID: 31288845
[TBL] [Abstract][Full Text] [Related]
16. Decreased frequencies of CD4+CD25+Foxp3+ cells and the potent CD103+ subset in peripheral lymph nodes correlate with autoimmune disease predisposition in some strains of mice.
Tucker CF; Nebane-Ambe DL; Chhabra A; Parnell SA; Zhao Y; Alard P; Kosiewicz MM
Autoimmunity; 2011 Sep; 44(6):453-64. PubMed ID: 21604973
[TBL] [Abstract][Full Text] [Related]
17. Peripheral CD4loCD40+ auto-aggressive T cell expansion during insulin-dependent diabetes mellitus.
Waid DM; Vaitaitis GM; Wagner DH
Eur J Immunol; 2004 May; 34(5):1488-97. PubMed ID: 15114683
[TBL] [Abstract][Full Text] [Related]
18. Transient Depletion of Foxp3
Watts D; Janßen M; Jaykar M; Palmucci F; Weigelt M; Petzold C; Hommel A; Sparwasser T; Bonifacio E; Kretschmer K
Front Immunol; 2021; 12():720133. PubMed ID: 34447385
[TBL] [Abstract][Full Text] [Related]
19. B7-1 and B7-2 differentially control peripheral homeostasis of CD4(+)CD25(+)Foxp3(+) regulatory T cells.
Zeng M; Guinet E; Nouri-Shirazi M
Transpl Immunol; 2009 Jan; 20(3):171-9. PubMed ID: 18848987
[TBL] [Abstract][Full Text] [Related]
20. Loss of invariant chain protects nonobese diabetic mice against type 1 diabetes.
Mellanby RJ; Koonce CH; Monti A; Phillips JM; Cooke A; Bikoff EK
J Immunol; 2006 Dec; 177(11):7588-98. PubMed ID: 17114428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
